Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6- associated Pemphigus vulgaris

BMC Bioinformatics

Volumn 7, Issue SUPPL.5, 2006, Pages

  Tong, Joo Chuan ^a,b   Tan, Tin Wee ^a   Sinha, Animesh A ^c   Ranganathan, Shoba ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE FOR INFOCOMM RESEARCH   (Singapore)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; DISEASE INITIATIONS; EXTRACELLULAR DOMAINS; IMMUNODOMINANT EPITOPES; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS; MOLECULAR MECHANISM; PEMPHIGUS VULGARIS; TRANSMEMBRANE REGIONS; BINDING PATTERN; BINDING PEPTIDE; CROSS-REACTIVITY; PEPTIDE BINDING; PEPTIDE SEQUENCES; PREDICTIVITY; SCORING FUNCTIONS; SKIN DISORDERS; STRUCTURE-BASED; T CELLS; T-CELL EPITOPES; T-CELL RESPONSE;

EPITOPES; GENES; PEPTIDES; PRESSES (MACHINE TOOLS); ANTIGENS; BIOINFORMATICS; DISEASES;

T-CELLS; PEPTIDES;

DESMOGLEIN 3; EPITOPE; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR4 ANTIGEN; HLA DR6 ANTIGEN; DSG3 PROTEIN, HUMAN; HLA DQ ANTIGEN; HLA DQB1*0503 ANTIGEN; HLA-DRB1 ANTIGEN; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; CROSS REACTION; DISEASE COURSE; MOLECULAR MECHANICS; PATHOGENESIS; PEMPHIGUS VULGARIS; PREDICTION; PROTEIN BINDING; PROTEIN DOMAIN; SCORING SYSTEM; T LYMPHOCYTE; BIOLOGY; CHEMISTRY; EVALUATION; HUMAN; IMMUNOLOGY; METHODOLOGY; MOLECULAR GENETICS; PEMPHIGUS; STATISTICAL MODEL;

AMINO ACID SEQUENCE; COMPUTATIONAL BIOLOGY; CROSS REACTIONS; DESMOGLEIN 3; DISEASE PROGRESSION; EPITOPES, T-LYMPHOCYTE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HLA-DR4 ANTIGEN; HLA-DR6 ANTIGEN; HUMANS; MODELS, STATISTICAL; MOLECULAR SEQUENCE DATA; PEMPHIGUS; PEPTIDE FRAGMENTS;

EID: 33947421277     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-7-S5-S7     Document Type: Article

References (52)

1. Carcassi C, Cottoni F, Floris L, Vacca A, Mulargia M, Arras M, Boero R, La Nasa G, Ledda A, Pizzati A, Cerimele D, Contu L: HLA haplotypes and class II molecular alleles in Sardinian and Italian patients with pemphigus vulgaris. Tissue Antigens 1996, 48:662-667.
2. Delgado JC, Hameed A, Yunis JJ, Bhol K, Rojas AI, Rehman SB, Khan AA, Ahmad M, Alper CA, Ahmed AR, Yunis EJ: Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients. Hum Immunol 1997, 57:110-119.
3. Loiseau P, Lecleach L, Prost C, Lepage V, Busson M, Bastuji-Garin S, Roujeau JC, Charron D: HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. J Autoimmun 2000, 15:67-73.
4. Miyagawa S, Higashimine I, Iida T, Yamashina Y, Fukumoto T, Shirai T: HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese. J Invest Dermatol 1997, 109:615-618.
5. Miyagawa S, Amagai M, Iida T, Yamamoto Y, Nishikawa T, Shirai T: Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression. Br J Dermatol 1999, 141:1084-1087.
6. Niizeki H, Inoko H, Narimatsu H, Takata H, Sonoda A, Tadakuma T, Ando A, Tsuji K, Hashimoto T, Nishikawa T: HLA class II antigens are associated with Japanese pemphigus patients. Hum Immunol 1991, 31:246-50.
7. Sinha AA, Brautbar C, Szafer F, Friedmann A, Tzfoni E, Todd JA, Steinman L, McDevitt HO: A newly characterized HLA DQ beta allele associated with pemphigus vulgaris. Science 1988, 239:1026-1029.
8. Scharf SJ, Friedmann A, Brautbar C, Szafer F, Steinman L, Horn G, Gyllensten U, Erlich HA: HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci U S A 1988, 85:3504-3508.
9. Amagai M, Klaus-Kovtun V, Stanley JR: Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991, 67:869-877.
10. Salato VK, Hacker-Foegen MK, Lazarova Z, Fairley JA, Lin MS: Role of intracellular epitope spreading in pemphigus vulgaris. Clin Immunol 2005, 116:54-64.
11. Veldman CM, Gebhard KL, Uter W, Wassmuth R, Grötzinger J, Schultz E, Hertl M: T cell recognition of desmoglein 3 peptides in patients with Pemphigus Vulgaris and healthy individuals. J Immunol 2004, 172:3883-3892.
12. Hertl M, Amagai M, Sundaram H, Stanley J, Ishii K, Katz SI: Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. J Invest Dermatol 1998, 110:62-66.
13. Wucherpfennig KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW, Ahmed AR, Strominger JL: Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: Charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci U S A 1995, 92:11935-11939.
14. Riechers R, Grotzinger J, Hertl M: HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: Review of the literature and potential applications for the development of a specific immunotherapy. Autoimmunity 1999, 30:183-196.
15. Chow S, Rizzo C, Ravitskiy L, Sinha AA: The role of T cells in cutaneous autoimmune disease. Autoimmunity 2005, 38:303-317.
16. Moesta M, Stevanovic S, Rammensee H-G, Lin M-S, Sinha AA: Identification of intracellular T cell epitopes in pemphigus vulgaris. J Invest Dermatol 2002, 119:319.
17. Schirle M, Weinschenk T, Stevanovic S: Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. J Immunol Methods 2001, 257:1-16.
18. Yu K, Petrovsky N, Schonbach C, Koh JY, Brusic V: Methods for prediction of peptide binding to MHC molecules: A comparative study. Mol Med 2002, 8:137-148.
19. Srinivasan KN, Zhang GL, Khan AM, August JT, Brusic V: Prediction of class I T-cell epitopes: Evidence of presence of immunological hot spots inside antigens. Bioinformatics 2004, 20(Suppl 1):i297-i302.
20. Parker KC, Bednarek MA, Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994, 152:163-175.
21. Davenport MP, Ho Shon IAP, Hill AVS: An empirical method for the prediction of T-cell epitopes. Immunogenetics 1995, 42:392-397.
22. Gulukota K, Sidney J, Sette A, DeLisi C: Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J Mol Biol 1997, 267:1258-1267.
23. Savoie CJ, Kamikawaji N, Sasazuki T, Kuhara S: Use of BONSAI decision trees for the identification of potential MHC class I peptide epitope motifs. Pac Symp Biocomput 1999.
24. Segal MR, Cummings MP, Hubbard AE: Relating amino acid sequence to phenotype: Analysis of peptide-binding data. Biometrics 2001, 57:632-642.
25. Brusic V, Rudy G, Harrison LC: Prediction of MHC binding peptides using artificial neural networks. In Complex Systems: Mechanism of Adaptation Edited by: Stonier RJ, Yu XS. Amsterdam: IOS Press; 1994:253-260.
26. Brusic V, Rudy G, Honeyman M, Hammer J, Harrison L: Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics 1998, 14:121-130.
27. Mamitsuka H: Predicting peptides that bind to MHC molecules using supervised learning of hidden Markov models. Proteins 1998, 33:460-474.
28. Dönnes P, Elofsson A: Prediction of MHC class I binding peptides, using SVMHC. BMC Bioinformatics 2002, 3:25.
29. Bhasin M, Raghava GPS: SVM based method for predicting HLADRB1*0401 binding peptides in an antigen sequence. Bioinformatics 2004, 20:421-423.
30. Bozic I, Zhang G, Orusic V: Predictive vaccinology: optimisation of predictions using support vector machine classifiers. IDEAL 2005:375-381.
31. Tong JC, Bramson J, Kanduc D, Chow S, Sinha AA, Ranganathan S: Modeling the bound conformation of pemphigus vulgarisassociated peptides to MHC class II DR and DQ alleles. Immunome Res 2006, 2:1.
32. Ranganathan S, Tong JC, Tan TW: Structural Immunoinformatics: Understanding MHC-peptide binding. In Advances in Experimental Medicine Series - Immunoinformatics: Opportunities and Challenges of Bridging Immunology with Computer and Information Sciences Edited by: Schoenbach C. Kluwer Plenum Press. accepted
33. Tong JC, Tan TW, Ranganathan S: Modeling the structure of bound peptide ligands to major histocompatibility complex. Protein Sci 2004, 13:2523-2532.
34. Tong JC, Zhang GL, Tan TW, August JT, Brusic V, Ranganathan S: Prediction of HLA-DQ3.2β ligands: Evidence of multiple registers in class II binding peptides. Bioinformatics 2006, 22:1232-1238.
35. Amagai M, Hashimoto T, Shimizu N, Nishikawa T: Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 1994, 94:59-67.
36. Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L, Metcalfe DD: A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 2004, 103:3222-3225.
37. Theophilos MB, Cox DW, Mercer JF: The toxic milk mouse is a murine model of Wilson disease. Hum Mol Genet 1996, 5:1619-1624.
38. Lin MS, Swartz SJ, Lopez A, Ding X, Fernandez-Vina MA, Stastny P, Fairley JA, Diaz LA: Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest 1997, 99:31-40.
39. Lee EY, Sinha AA: T cell targeted therapy for autoimmune disease. Autoimmunity 2005, 38:577-596.
40. Sinha AA, LopezTMT, McDevitt HO: Autoimmune diseases: the failure of self-tolerance. Science 1990, 248:1380-1388.
41. Robinson J, Waller MJ, Parham P, de Groot N, Bontrop R, Kennedy LJ, Stoehr P, Marsh SS: IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 2003, 31:311-314.
42. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissiq H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res 2000, 28:235-242.
43. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
44. Sali A, Blundell TL: Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993 234:779-815.
45. MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, et al.: All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem 1998, B102:3586-3617.
46. Abagyan R, Totrov M, Kuznetsov D: ICM - a new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation. J Comput Chem 1994, 15:488-506.
47. Abagyan RA, Totrov M: Ab initio folding of peptides by the optimal-bias Monte Carlo minimization procedure. J Comput Phys 1999, 151:402-421.
48. Zauhar RJ, Morgan RS: A new method for computing the macromolecular electric potential. J Mol Biol 1985, 186:815-820.
49. Bharadwaj A, Windemuth A, Sridharan S, Honig B, Nicholls A: The fast multipole boundary element method for molecular electrostatics: An optimal approach for large system. J Comput Chem 1995, 16:898-910.
50. Schapira M, Totrov M, Abagyan R: Prediction of the binding energy for small molecules, peptides and proteins. J Mol Recognit 1999, 12:177-190.
51. Janin J: Protein-protein recognition. Prog Biophys Mol Biol 1995, 64:145-166.
52. Rognan D, Lauemoller SL, Holm A, Buus S, Tschinke V: Predicting binding affinities of protein ligands from three-dimensional models: Application to Peptide Binding to Class I Major Histocompatibility Proteins. J Med Chem 1999, 42:4650-4658.